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ABSTRACT
Background: Women without cardiovascular disease (CVD) or hypertension at baseline assigned to intervention in the Women’s Health Initiative
Dietary Modification (DM) trial experienced 30% lower risk of coronary heart disease (CHD), whereas results in women with hypertension or prior
CVD could have been confounded by postrandomization use of statins.
Objectives: Intervention participants reported various self-selected changes to achieve the 20% total fat goals. Reviewed are intervention
compared with comparison group HRs for CHD, stroke, and total CVD in relation to specific dietary changes in normotensive participants.
Methods: Dietary change was assessed by comparing baseline with year 1 FFQ data in women (n = 10,371) without hypertension or CVD at
baseline with intake of total fat above the median to minimize biases due to use of the FFQ in trial eligibility screening.
Results: Intervention participants self-reported compensating reduced energy intake from total fat by increasing carbohydrate and protein.
Specifically they increased plant protein, with those in the upper quartile (increased total protein by ≥3.3% of energy) having a CHD HR of 0.39
(95% CI: 0.22, 0.71), compared with 0.92 (95% CI: 0.57, 1.48) for those in the lower quartile of change (decreased total protein ≥0.6% of energy),
with P-trend of 0.04. CHD HR did not vary significantly with change in percentage energy from carbohydrate, and stroke HR did not vary
significantly with any macronutrient changes. Scores reflecting adherence to recommended dietary patterns including the Dietary Approaches to
Stop Hypertension Trial and the Healthy Eating Index showed favorable changes in the intervention group.
Conclusions: Intervention group total fat reduction replaced with increased carbohydrate and some protein, especially plant-based protein, was
related to lower CHD risk in normotensive women without CVD who reported high baseline total fat intake. This trial was registered at
clinicaltrials.gov as NCT00000611. Link to the WHI trial protocol: https://www.whi.org/about/SitePages/Dietary%20Trial.aspx. Curr Dev Nutr
2020;4:nzaa021.
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Introduction
The Women’s Health Initiative (WHI) Diet Modification Trial (DMT)
was a randomized clinical trial of 48,835 postmenopausal women in the
United States with a primary aim of testing whether a low-fat (20% of
total calories) dietary pattern intervention including 5 servings of fruits
and vegetables and 6 servings of grains per day, would reduce the inci-
dence of breast cancer and colorectal cancers. Coronary heart disease
(CHD) was the designated secondary outcome. Prentice et al. (1) re-
ported a significant risk reduction for CHD (HR: 0.70; 95% CI: 0.56,
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0.87) in normotensive women without a prior history of cardiovascular
disease (CVD), defined as self-report before randomization of myocar-
dial infarction, coronary artery bypass graft, or stroke. Hypertension
was defined as self-report of ever taking medication for hypertension
before randomization, or clinic-measured systolic/diastolic blood pres-
sure (SBP/DBP) ≥140/90 mm Hg, at randomization. This result was
statistically significant even after adjustment for multiple comparisons
of the 15 subgroups considered in the original DMT and cardiovascular
disease report (2) (Bonferroni-corrected P = 0.001). Conversely there
was a possible elevation in stroke risk (HR: 1.29; 95%CI: 1.00, 1.66), but
this was not apparent after allowing for multiple testing.
In normotensive women without a history of CVD, there was no
evidence of postrandomization confounding by changes in antihy-
pertensive and/or cholesterol-lowering medications based on periodic
medication inventories in the trial cohort (1). In contrast, there was
evidence of postrandomization group imbalances in starting and stop-
ping these medications in women with hypertension without prior
CVD, as well as those with a prior history of CVD. For this latter group
LDL-cholesterol values tended to increase during trial follow-up in the
intervention group, even during a time of rapid increase in statin use,
whereas LDL-cholesterol values dropped in the comparison group. This
and periodic medication inventories were consistent with postrandom-
ization confounding by statin use in participants who had hypertension
or prior CVD (1). This report therefore focuses exclusively on partici-
pants who were normotensive at baseline (SBP/DBP <140/90 mmHg)
and not taking medication for high blood pressure (see Figure 1) and
were without prior CVD. These participants, who represent a substan-
tial percentage of the population, self-selected a variety of approaches
to achieve the dietary changes needed to meet low-fat dietary pattern
goals. Participants were coached on lowering total fat, but not specifi-
cally on the type of fats to reduce. Some, but not all, of the eating pattern
changes made individually were consistent with dietary recommenda-
tions for cardiovascular health (e.g., greater reduction in saturated than
unsaturated fat; increased dietary fiber, fruits, vegetables, low-fat dairy
products, whole grains).
Because of the potential for dissemination of these preventive di-
etary strategies across the broader population, the WHI DMT provides
a unique opportunity to specifically study the impact of postrandom-
ization dietary changes made to achieve low-fat diet study goals using
self-reported FFQ data, and their subsequent effects on CHD, stroke,
and overall CVD.
Methods
Analytical sample
Methods and initial results for the DMT have been previously reported
(2–4). Briefly, all women (n = 48,835) were postmenopausal and in the
age range of 50–79 y at randomization and signed Institutional Review
Board approved written consent at all 40 clinical centers. Intervention
participants (40% of the DMT participants) were randomly allocated
to a behavioral low-total-fat diet intervention program administered
by trained nutritionists in groups of 8–15 individuals (Figure 1). There
were 18 group sessions in the first year and quarterly sessions there-
after. Nutritional concepts and behavioral skills were presented to help
achieve the DMT goals: reduce total fat to 20% of total energy intake;
increase vegetable and fruit intake to ≥5 servings/d; and increase grain
intake to ≥6 servings/d. There were no specific instructions regarding
the types of fat to reduce, nor the compensatory carbohydrate, protein,
or fatty acids to increase. The comparison group (60% of the DMT) re-
ceived printed health-related materials only.
Dietary intake was assessed in both groups by periodic, self-
administered FFQs (5), adapted from the Health Habits and Lifestyle
Questionnaire (6). Three sections of the WHI FFQ included 122 com-
posite and single-food items documenting frequency of consumption
and portion size, 19 adjustment questions regarding type of fat intake,
and 4 summary questions about usual intake of fruits, vegetables, and
added fats for comparison with information gathered from the specific
food items. The nutrient database used to analyze theWHI FFQwas de-
rived from theNutritionData Systems for Research (7), providing nutri-
ent information for >140 nutrients and compounds, including energy,
saturated fat, and sodium (7, 8).
The baseline FFQ percentage of energy from fat in the DMT tended
to be upwardly distorted due to use in eligibility screening, with greater
distortions in those whose total fat intake was just above the 32% cut-
off. The FFQ assessment has considerable noise, and women who met
eligibility criteria tended to have a percentage fat assessment that was
substantially biased upward. To mitigate this problem DMT enrollees
whose baseline percentage energy from fat was below the median were
excluded and thus dietary screening influences on FFQ assessments
were minimized (see Figure 1). Also, FFQ data can have better mea-
surement properties for dietary change (e.g., year 1 minus baseline)
compared with FFQ data at a particular time point (e.g., year 1) be-
cause systematic biases, related to participant characteristics such as
BMI, age, and race/ethnicity (9), will tend to be “differenced out” of
the dietary change assessment. Women with implausible energy intakes
<600 kcal/d or>5000 kcal/d were excluded.
Cut points used to define normotensive participants at baseline
were SBP/DBP <140/90 mmHg, and no prior medication use for high
blood pressure. Staff measured height, weight, and waist circumference
among other clinical parameters. Comparisons between the normoten-
sive women and those with CVD at baseline are presented in the Sup-
plemental Tables.
The study protocol was reviewed and approved by the FredHutchin-
sonCancer ResearchCenter Institutional ReviewBoard (Protocol 6299)
in Seattle, WA, where theWHI Clinical Coordinating Center is located,
and by the institutional review boards at each of the 40 participating
clinical centers.
Statistical analyses
Cox regressionmodels used in our previous report (1) were extended by
adding HR interaction terms defined as changes in postrandomization
FFQ data (year 1 minus baseline) with time-origin for follow-up begin-
ning at the year 1 FFQ. Specifically, the CHDHR function was modeled
by including the randomization indicator variable (Z = 0 for compar-
ison group; Z = 1 for intervention group) and a product term defined
as Z multiplied by change in percentage of energy from carbohydrates,
modeled as a continuous linear variable. The model also included in-
teraction terms for changes in percentage of energy from protein and
alcohol. These macronutrient regression terms were normalized to be
perfectly colinear with fat so that an increase of 14%, 1%, and 0% of en-
ergy from carbohydrates, protein, and alcohol, for example, necessarily
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373,092 Women initiated screening
56,139 Provided consent and met the ≥ 32% 
energy from fat eligibility criterion
48,835 Randomly assigned
(19,541 Assigned to receive low-fat diet)
(29,294 Assigned to receive usual diet)
23,248 Normotensive1 and without prior history of CVD2
11,578 Consumed ≥ 36.6% (median) energy from fat
4707 Assigned to receive low-fat diet
4361 Had any follow-up after year 13 
- 116 Excluded for implausible 
energy intake4
6126 Included in analysis 
140 Deceased
110 Stopped Follow-up
45 Lost
6871 Assigned to receive usual diet
6268 Had any follow-up after year 13 
- 142 Excluded for implausible 
energy intake4
216 Deceased
105 Stopped Follow-up
32 Lost
4245 Included in analysis 
FIGURE 1 Participant flow diagram. Participant flow diagram for the Women’s Health Initiative trial of a low-fat dietary pattern in women
without hypertension or prior history of CVD at baseline but who reported intake of total fat above the median. All participants were
postmenopausal and in the age range 50–79 y when enrolled during 1993–1998 at 40 US clinical centers. 1Hypertension was defined as
self-report of ever taking medication for hypertension before randomization, or clinic-measured systolic/diastolic blood pressure ≥140/90
mm Hg. 2Prior history of CVD was defined as self-report before randomization of MI, CABG/PCI, or stroke. 3Time-origin for Cox regression
models began at year 1. 4Implausible energy intakes of <600 kcal/d or >5000 kcal/d. CABG/PCI, coronary artery bypass
graft/percutaneous coronary intervention; CVD, cardiovascular disease; MI, myocardial infarction.
corresponds to a 15% decrease in energy from total fat. To summarize
the clinical relevance of these estimated regression coefficients, corre-
sponding HR estimates were computed at the average change in eating
pattern reported by the intervention group for these macronutrients,
within quartiles of change for carbohydrate intake. HRs were also es-
timated by quartiles of change in protein intake. Exploratory analyses
examined the potential for differential influence by source of macronu-
trient (e.g., animal compared with plant-based protein), by replacing
the macronutrient interaction (e.g., Z multiplied by change in energy
from protein) with source-specific interaction terms (e.g., Z multiplied
by changes in energy from animal and plant-based protein).
To address potential confounding related to starting the follow-up
period at 1 y postrandomization (the earliest postrandomization time
for full cohort dietary assessment), Cox regression models included
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distinct baseline hazard functions stratified by 5-y age group, BMI
(<25; 25 to <30; 30 to <35; >35 kg/m2), race/ethnicity (white; black;
Hispanic; other), FFQ percentage energy from fat (quintiles), random-
ization status in the hormone therapy trials, and hysterectomy status,
along with linear regression terms for age, BMI, and baseline FFQ per-
centage energy from fat. The first 3 stratifying variables are strong cor-
relates of total energy, for which FFQ estimates include major sys-
tematic biases (9). The stratification by, and regression modeling of,
baseline FFQ percentage energy from fat aims to ensure that HR es-
timates were derived from women having similar baseline percentage
energy from fat. Forest plots displayed whether HR estimates were in-
fluenced by pertinent study subject characteristics. Residual diagnos-
tics assessed robustness of model fit (10). To elucidate potential mecha-
nisms, linear regression models, which also included product terms for
the interaction between randomization group and change in percent-
age of energy from macronutrients, were fit with changes in compo-
nents of metabolic syndrome (year 1 minus baseline) as the dependent
variable.
Scores for common diet quality indices were also computed to char-
acterize dietary changes in the intervention, and included: the Healthy
Eating Index (HEI)-2005 (11); Dietary Approaches to Stop Hyperten-
sion Trial (DASH) diet score (12, 13); Alternative Healthy Eating Index
(AHEI)-2010 (14); and the Alternate Mediterranean Diet (aMed) score
(15, 16); score definitions are summarized in Supplemental Table S1.
“Effects sizes” (17)were used to graphically quantify the healthfulness of
the intervention according to diet quality scores, and to facilitate com-
parisons across scores; effect size = (mean change of the intervention
group minus comparison group divided by their pooled SD).
Cox model analyses are presented as HRs with 95% CIs and nomi-
nal 2-sided significance levels. Analyses were performed with SAS 9.4
software (SAS Institute), and figures produced with R 3.2 software (R
Foundation for Statistical Computing).
Results
Of the total DMT normotensive cohort (n= 23,348 participants), base-
line characteristics and eating patterns for the 10,371 normotensive par-
ticipants without CVD at baseline who consumed≥36.6% energy from
total fat (themedian FFQ consumption of this group) were balanced be-
tween groups (Table 1). On average, this subgroup reported consuming
∼41% of calories from total fat, a nearly equal amount from total carbo-
hydrates, and 16% energy from total protein with three-fourths derived
from animal sources.
The normotensive intervention group reported changes in their di-
etary habits at 1 y postrandomization that were substantially different
from baseline and from the comparison group, who reported minimal
dietary change (Table 2). The noteworthy reduction reported in per-
centage of energy from total fat, manifested in all types of fats (satu-
rated, polyunsaturated, monounsaturated, and trans-fat), were mostly
replaced by increased percentage of energy from total carbohydrates,
including added sugar sources. On average, there was a comparatively
modest increase in percentage of energy from total protein relative to
the comparison group, exclusively due to a significant self-reported in-
crease in plant protein, independent of change in energy from animal
protein. The increase in plant protein had little variability in interven-
tion participants (CV = SD/mean = 1.0; Table 2), whereas change in
animal protein was rather variable (CV = 17.5). Small reductions in
body weight, central adiposity, and blood pressure were observed for
this cohort of relatively high-fat eaters at baseline (≥36.6% energy from
fat) randomly assigned to the intervention.
Overall, all 4 diet quality scores improved in relation to assignment
to the intervention (P< 0.001), but the magnitude of change varied ac-
cording to scoring system (Figure 2). The effect size for dietary change
was largest for HEI 2005, followed by DASH, but more modest when
scored by AHEI and aMed. Across all scores, the intervention had a fa-
vorable influence on components related to increased consumption of
fruit, vegetables, and whole grains. Consumption of legumes also in-
creased, when scored separately from nuts and seeds (aMed). Compo-
nents of diet scores that emphasized low-fat dairy consumption (HEI,
DASH) were favorably changed, but components of scores that empha-
sized fish (EPA + DHA aspect of AHEI and aMed) and other unsatu-
rated fatty acids were unchanged. Improvements in diet quality scores
(Figure 2) were related mostly to reduced saturated fat and trans-fat
intakes.
The CHD HR for this analytic cohort of participants with rela-
tively high baseline fat intake (HR = 0.67; Figure 3) was similar to
results reported by Prentice et al. (1) for the full normotensive cohort
(HR = 0.70), and not significantly different from the HR of partici-
pants who consumed lower percentage energy from total fat and were
excluded (HR = 0.76; P-interaction = 0.55). The HR was robust to
choice of timescale (time from baseline compared with time from year
1; HR = 0.68 when follow-up starts at year 1 FFQ) and to fine multi-
variable adjustment for potential confounding factors through extensive
stratification (HR = 0.63 following adjustment).
Simultaneous inclusion of intervention group interaction
terms for change in percentage of energy from carbohydrates
(P-interaction = 0.89; Supplemental Table S2), protein (P-
interaction = 0.04), and alcohol indicated that the HR reduction
for CHD was significantly enhanced in intervention group participants
who made relatively larger increases in percentage of energy from
protein.
Corresponding HR estimates (Figure 3; lower half) evaluated at the
average change in eating pattern reported by the intervention group
for these macronutrients, illustrate that the reduction in CHD risk was
significantly enhanced with increasing protein, particularly vegetable
protein consumption (P-trend = 0.04). For example, in participants
who made the largest increase in protein consumption (upper quar-
tile; Supplemental Table S3), the average change in percentage energy
fromprotein (+5.3%), carbohydrates (+11.9%), and alcohol (0.1%)was
necessarily offset by a commensurate reduction in fat (−17.3%) that
corresponded to a fitted HR = 0.39 (95% CI: 0.22, 0.71). In contrast,
the reduction in CHD risk showed little association with the magnitude
of carbohydrate increase (P-trend= 0.89), with larger carbohydrate in-
creases corresponding to relatively larger fat decreases and also to rela-
tively small protein increases (Figure 3; Supplemental Table S4).
Similar analyses were performed for stroke and total CVD but the
interactions with change in percentage of energy from protein (P-
interaction = 0.83 and P-interaction = 0.07, respectively; Supplemen-
tal Tables S5 and S6) and carbohydrates (P-interaction = 0.19 and
P-interaction = 0.09, respectively). Additional analyses of the signif-
icant interaction of protein content with CHD differentiated between
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TABLE 1 Baseline characteristics of normotensive dietary trial participants who consumed ≥36.6% energy from fat without
history of CVD by randomization group (n = 10,371)
Intervention (n = 4245) Comparison (n = 6126)
Age at screening, y 61.3 ± 6.6 61.1 ± 6.6
Race/ethnicity
White 3579 (84.3) 5227 (85.3)
Black 339 (8.0) 439 (7.2)
Hispanic 182 (4.3) 211 (3.4)
American Indian/Alaskan Native 13 (0.3) 16 (0.3)
Asian/Pacific Islander 81 (1.9) 138 (2.3)
Unknown 51 (1.2) 95 (1.6)
Smoking
Never 2117 (50.4) 3095 (50.9)
Past 1708 (40.7) 2443 (40.2)
Current 375 (8.9) 537 (8.8)
Hypertensive medication 275 (6.5) 366 (6.0)
History of high cholesterol requiring pills 304 (7.3) 441 (7.3)
Statin use 149 (3.5) 231 (3.8)
Treated diabetes (pills or shots) 98 (2.3) 140 (2.3)
Aspirin use 592 (13.9) 936 (15.3)
BMI, kg/m2 28.4 ± 5.7 28.3 ± 5.5
Height, cm 162.5 ± 6.5 162.5 ± 6.7
Weight, kg 75.3 ± 15.9 75.0 ± 15.7
Waist circumference, cm 87.4 ± 13.4 87.1 ± 13.1
Systolic BP, mm Hg 118.6 ± 11.3 118.5 ± 11.2
Diastolic BP, mm Hg 72.8 ± 7.5 72.9 ± 7.4
Dietary energy, kcal 1886.6 ± 740.1 1877.9 ± 725.7
Percentage calories from:
Fat 41.5 ± 3.9 41.4 ± 3.9
SFAs 14.0 ± 2.5 14.0 ± 2.5
Polyunsaturated fatty acids (PUFAs) 8.5 ± 2.1 8.4 ± 2.1
Monounsaturated fatty acids (MUFAs) 15.9 ± 1.9 15.8 ± 2.0
TFAs 3.0 ± 1.2 3.0 ± 1.2
Carbohydrates 42.2 ± 5.3 42.4 ± 5.4
Added sugar 10.8 ± 4.5 10.8 ± 4.5
Other sources 31.5 ± 5.0 31.6 ± 5.1
Protein 16.1 ± 2.9 16.0 ± 2.8
Animal protein 11.7 ± 3.1 11.6 ± 3.1
Vegetable protein 4.4 ± 1.0 4.4 ± 1.0
Alcohol 1.7 ± 2.9 1.6 ± 2.8
Fruits/vegetables, med serv/d 3.3 ± 1.7 3.3 ± 1.7
Grains, med serv/d 4.7 ± 2.5 4.7 ± 2.5
Dietary fiber, g/d 14.8 ± 6.1 14.8 ± 6.1
Dietary cholesterol, mg/d 288.5 ± 150.4 286.2 ± 142.2
Diet quality scores1
Healthy Eating Index-20052 60.1 ± 9.3 60.1 ± 9.5
Alternate Mediterranean Diet score3 4.0 ± 1.7 4.0 ± 1.7
Alternative Healthy Eating Index 20104 49.1 ± 9.7 49.0 ± 9.9
Adherence to DASH score5 23.4 ± 4.3 23.3 ± 4.4
1Diet quality scores are summarized in Supplemental Table S1.
2Healthy Eating Index-2005 scores range from 0 (worst) to 100 (best).
3Alternate Mediterranean Diet ranges from 0 (worst) to 9 (best).
4Alternative Healthy Eating Index 2010 ranges from 0 (worst) to 110 (best).
5DASH score ranges from 8 (worst) to 40 (best).
sources of protein (animal compared with plant), but yielded similar
regression coefficients (Supplemental Table S7), so did not suggest
differential benefit (P-heterogeneity = 0.87). Additional exploratory
analyses that differentiated between sources of carbohydrates (added
sugar compared with other) did not suggest a differential effect (P-
heterogeneity= 0.22). Further analyses investigated an interaction term
for unsaturated fat, where its coefficient can be interpreted in terms
of replacing energy from saturated and trans-fats by unsaturated fat,
but this interaction was not significant (P-interaction = 0.78). How-
ever, reported decreases in percentage energy from unsaturated fat cor-
related strongly with reported decreases in percentage energy from
saturated and trans-fat, so there was little ability to examine the in-
fluence of this type of fat substitution (Supplemental Tables S3, S4,
and S8).
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TABLE 2 Change (year 1 minus baseline) of selected participant characteristics of normotensive dietary trial who
consumed ≥36.6% energy from fat without prior history of CVD by randomization group (n = 10,371)1
Intervention (n = 4245) Comparison (n = 6126) P value
Dietary targets2
Percentage of energy from total fat 25.3 ± 7.9 37.7 ± 6.8 <0.001
Fruits/vegetables, med serv/d 4.9 ± 2.3 3.6 ± 1.9 <0.001
Grains, med serv/d 5.1 ± 2.6 4.3 ± 2.3 <0.001
Dietary fiber,3 g/d 17.7 ± 7.1 14.5 ± 6.1 <0.001
Percentage change in energy from:
Total fat −16.2 ± 8.3 −3.8 ± 6.4 <0.001
Saturated fat −5.6 ± 3.4 −1.3 ± 2.8 <0.001
Polyunsaturated fat −3.1 ± 2.4 −0.8 ± 2.2 <0.001
Monounsaturated fat −6.6 ± 3.5 −1.5 ± 2.8 <0.001
Trans-fat −1.3 ± 1.3 −0.4 ± 1.1 <0.001
Carbohydrates 15.1 ± 9.0 3.3 ± 7.0 <0.001
Added sugar 1.3 ± 4.9 0.3 ± 4.5 <0.001
Other sources 13.8 ± 8.7 3.0 ± 6.6 <0.001
Protein 1.5 ± 3.2 0.5 ± 3.0 <0.001
Animal protein 0.2 ± 3.5 0.3 ± 3.2 0.15
Vegetable protein 1.3 ± 1.3 0.2 ± 1.1 <0.001
Alcohol 0.4 ± 2.4 0.2 ± 2.1 <0.001
Change in dietary cholesterol, mg/d − 110.5 ± 138.6 −37.2 ± 128.3 <0.001
Change in participant characteristics:
Weight, kg −2.4 ± 7.7 0.2 ± 8.8 <0.001
Waist circumference, cm −2.0 ± 6.6 −0.1 ± 6.6 <0.001
Systolic BP, mmHg −0.6 ± 12.4 0.5 ± 12.2 <0.001
Diastolic BP, mmHg −1.3 ± 7.8 −0.4 ± 7.6 <0.001
1Change values are mean ± SD. BP, blood pressure; CVD, cardiovascular disease; med serv, medium serving.
2Intervention goals were 20% of energy from total fat, ≥5 servings of vegetables and fruit per day, and ≥6 servings of grains per day.
3Dietary fiber was not an intervention goal, but can be helpful in distinguishing between changes in complex vs. refined carbohydrates. The mean change in fiber was
3.0 ± 6.9 and − 0.3 ± 5.3 g/d in the intervention and comparison groups, respectively; P value < 0.001.
Exploratory analyses examined components of metabolic syndrome
associated with eating patterns changes (Figure 4).Waist circumference
decreasedwith increased protein consumption (P-trend< 0.001; Figure
4, left side) with tempered increase in total carbohydrates (Supplemen-
tal Table S3). Larger increases in carbohydrate intake, and diminishing
increases in animal protein (Supplemental Table S4), were also asso-
ciated with decreased waist circumference (P-trend < 0.001; Figure 4,
right side), and decreased systolic (P-trend < 0.001) and diastolic
(P-trend < 0.001) blood pressure, but also reduced HDL-cholesterol
(P-trend = 0.02).
Discussion
These analyses examined the self-selected dietary changesmade by nor-
motensive intervention participants that were accompanied by signifi-
cant reductions in their risk of CHD (1). In the full normotensive cohort
(HR= 0.70; n= 23,348) and those above the median intake of percent-
age energy from total fat (HR= 0.67; n= 10,371), the significant reduc-
tion in CHDwas associated with an eating pattern that replaced energy
from total fatwith total carbohydrate and a small increase in plant-based
vegetable protein, primarily derived from beans and legumes. Interven-
tion participants chose varying approaches to achieve dietary goals, and
specifically toward reducing total fat intake to <20% of energy intake.
The HR reduction for CHD was significantly enhanced in intervention
group participants who reported increased percentage energy intake
from protein, especially plant-based protein. These findings suggest im-
provement in CHD risk reduction in these normotensive participants
with baseline high fat intake by substituting total protein, as well as car-
bohydrate, for total fat.
WHI nutritionists presented 18 standardized group sessions dur-
ing the first year, integrating diet and nutrition principles with be-
havioral concepts aimed at application (18, 19). The first 6 weekly
sessions focused on total fat reduction by identifying major sources
and introducing skills needed to achieve fundamental changes includ-
ing label reading and navigating restaurant menus (18, 19). Selection,
economic value, and preparation techniques for dark-green vegeta-
bles and legumes were emphasized as options for nondairy sources
of calcium (Session #3), low-fat alternatives for meat protein (Ses-
sion #5), and sources of complex carbohydrates high in vegetable pro-
tein and dietary fiber (Session #14). Few participants chose to in-
crease intake of soy foods (Session #2), or nuts and seeds (Session
#2) to achieve the low-fat goal, but beans and legumes were increased.
Group maintenance sessions that occurred quarterly following the first
year reinforced the recommended preparation techniques and nutrition
principles.
Percentage of energy intake specifically from animal protein foods
did not differ between randomization groups, consistent with interven-
tions that focused on substituting fish, poultry, or leaner cuts of meat
for red or processed meat (20) (Session #5). Participants did not choose
to increase fish intake (2, 4) but favored other fat-reduction strategies,
including avoidance of fried foods or substituting jam for butter ormar-
garine, as reflected by increased percentage energy from added sugar
intake.
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FIGURE 2 Diet quality scores by randomization group among normotensive participants consuming a high-fat diet at baseline. Mean
(SD) change (year 1 minus baseline) and effect size of diet quality scores by randomization group in normotensive participants who
consumed ≥36.6% energy from fat without a history of CVD (n = 10,371); diet quality scores are summarized in Supplemental Table S1.
Changes in diet quality scores are ranked by effect size (best to worst) to facilitate comparisons between scores. Likewise, components are
ranked to facilitate within-score comparisons. Vertical reference lines indicate effects that are large (0.8 SD), median (0.5 SD), and small
(0.2 SD) (17). Diet quality scores and components can have different ranges, so mean (SD) should not be compared across or within scores.
AHEI, Alternative Healthy Eating Index; aMed, Alternate Mediterranean Diet; CVD, cardiovascular disease; DASH, Dietary Approaches to
Stop Hypertension Trial; HEI, Healthy Eating Index.
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FIGURE 3 HRs in normotensive participants consuming a high-fat diet at baseline. Forest plot of HR estimates by pertinent study subject
characteristics in normotensive participants who consumed ≥36.6% energy from fat without a history of CVD (n = 10,371). Fitted HRs
(lower half; intervention vs. comparison) for CHD risk are based on the estimated regression coefficients (Supplemental Table S2)
evaluated at the average eating patterns reported by the intervention group overall and for increasing changes in energy from protein
(Supplemental Table S3) and carbohydrates (Supplemental Table S4). For example, the HRs (0.92, 0.67, 0.55, 0.39) that correspond to
increasing change in energy from protein (quartiles: <−0.6%, −0.6 to <1.3%, 1.3 to <3.3%, ≥3.3%) were computed from the regression
coefficients at the observed (average) change in energy from protein (−2.6, 0.4, 2.2, 5.3%), carbohydrates (17.1, 14.6, 14.1, 11.9%), and
alcohol (0.7, 0.4, 0.3, 0.1%); these changes offset the observed decrease in energy from total fat (−15.3, −15.3, −16.6, −17.3%). P values
for fitted HRs correspond to tests for trend of the observed eating pattern and are intended to complement, not supersede, P values for
specific HR interactions shown in Supplemental Table S2. CHD, coronary heart disease; CVD, cardiovascular disease.
Although increased consumption of low-fat dairy was not a de-
fined intervention goal the intervention group increased their intake of
these foods, thereby resulting in improved HEI scores and especially
DASH scores. Intervention sessions in these postmenopausal women
emphasized the importance of dietary calcium as essential for bone
health that could be maintained by substituting low- or nonfat dairy for
high-fat sources (Session #3) similar to eating behavior observed in the
antecedent Women’s Health Trial (18). Neither the aMed nor AHEI
scoring algorithms specify low-fat dairy as a measure of diet quality
for disease prevention (14, 15), nor was dairy promoted as part of the
Mediterranean diet in the Prevencion con Dieta Mediterranea (PRED-
IMED) Trial (21). The seminal paper on theMediterranean dietary pat-
tern by Trichopoulou et al. (16) favored low intake of dairy products.
The observed contrast in eating patterns between the WHI DMT
groups is more consistent with the landmark DASH feeding trials
(13, 22, 23). The DASH “combination diet” rich in fruits, vegetables,
and low-fat dairy, included less total and saturated fat and choles-
terol, and larger amounts of potassium, calcium, magnesium, dietary
fiber, and protein than the typical American diet. The DASH “fruit
and vegetable diet” was intended to provide higher amounts of potas-
sium, magnesium, and fiber. After 8 wk, both the DASH “combi-
nation diet” and “fruit and vegetable diet” significantly reduced sys-
tolic blood pressure, by 5.5 mmHg and 2.8 mmHg, respectively (13).
The 2 DASH diets reduced LDL-cholesterol, by 10.7 mg/dL and
1.9 mg/dL, respectively, but only the combination diet achieved sta-
tistical significance (24). Of note, a significant 1.2-mmHg reduction in
systolic blood pressure was observed in the WHI normotensive cohort
reported here at year 1, with a smaller reduction reported in the full
WHI cohort (1, 25), along with a significant 1.9-mg/dL reduction in
LDL-cholesterol (1).
Adjuncts to a DASH diet (OmniHeart), regarding LDL-cholesterol
and systolic blood pressure, were demonstrated (26) by partial substitu-
tion of protein, about half from plant sources, or monounsaturated fat
for total carbohydrate. The DASH diet was further enhanced and favor-
ably affected a wider range of lipoproteins, by substituting unsaturated
fat and protein for total carbohydrate, but no improvement was noted
in insulin sensitivity (27).
In the setting of a designated clinical outcome for theWHI interven-
tion, dietary changes that achieved greater protein density accompanied
by relatively smaller increases in carbohydrate density were associated
with further reduced incidence of CHD (28). The catalyzing 30% sig-
nificant reduction in CHD risk (1) reported in the full cohort of nor-
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FIGURE 4 Changes in metabolic syndrome components among normotensive participants consuming a high-fat diet at baseline. Forest
plot of estimated average change (intervention vs. comparison) for metabolic syndrome components in normotensive participants who
consumed ≥36.6% energy from fat without a history of CVD (n = 10,371). Estimates of change are based on the estimated regression
coefficients evaluated at the average eating patterns reported by the intervention group for increasing changes in energy from protein
(Supplemental Table S3) and carbohydrates (Supplemental Table S4). Laboratory measurements based on a 5.8% subsample of trial
participants. Because of skewed distributions glucose and triglycerides were log-transformed and ratios of geometric means were
presented. BP, blood pressure; CVD, cardiovascular disease; HDL-C, HDL-cholesterol.
motensive women (n = 23,248) corresponded to a higher average total
protein intake in the intervention group compared with the compari-
son group (17.6% compared with 16.8% at year 1) (1), specifically from
increased plant-based protein sources (5.8 compared with 4.8%), with
no increase in animal protein (11.8 compared with 11.9%). The present
analysis did not reveal this differential benefit between protein sources
(P-heterogeneity = 0.87) but the choice of a higher protein diet had fa-
vorable CHD results. In addition, beans are scored by the HEI as a pro-
tein source only after the vegetable requirement has been met, thereby
further influencing these scores (29).
There was no evidence to suggest that these dietary pattern changes
differently influenced incidence of stroke, not a protocol-designated
outcome, inwomenwhodid or did not have hypertension. In contrast to
major benefits in stroke reduction reported by PREDIMED’s Mediter-
ranean diets (21), a possible increased stroke risk among normotensive
intervention women without prior CVD in the DMT could have been
due to chance. As noted by Appel and Van Horn (30) other than the
extra virgin olive oil and nuts, there were no major differences in nu-
trient or food group content compared with the PREDIMED control
diet. Both PREDIMED Mediterranean diet groups increased nut con-
sumption, relative to the control diet that, in Spain, inherently includes
more olive oil than is typically consumed in the United States. WHI’s
intervention group avoided nuts and reduced all sources of oil intake in
efforts to achieve the low-fat goal.
Small decreases in systolic blood pressure were associated with car-
diovascular events in large clinical trials (31), but changes in blood pres-
sure did not explain the observed CHD benefit. Reduced total fat intake
substituted with increased protein intake accompanied lower energy in-
take and reduced CHD (Figure 3), but weight loss that accompanied a
2.54-cm (1-inch) reduction in waist circumference can only partially
explain this result (Figure 4). Whether involvement of inflammatory,
microbial, or other cardiovascular biomarkers as mediators of favorable
CHD risk reduction influences is associated with these dietary pattern
changes is under investigation (32–34).
Study strengths include long-term follow-up of a large cohort
(n = 10,371) within a randomized clinical trial that reinforced dietary
changes throughout the trial intervention period (35), demonstrating
self-selected response to a dietary behavioral intervention similar to
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outpatient nutrition programs recommended throughout the United
States (36).
Limitations include the self-reported FFQdata that preventmore de-
tailed analyses of eating patterns and sources of vegetable protein intake
(Supplemental Table S3). Also, the FFQdatamight incorporate substan-
tial random and systematic biases. The influence of systematic bias can
be expected to be reduced for the dietary change FFQ data as used in
our principal analyses, compared with the contributing FFQ estimates,
because of differencing out biases related to such characteristics as BMI,
age, or race/ethnicity. Random biases can be expected to primarily at-
tenuate the estimated interactionHRs toward the null, thereby reducing
the strength of evidence for interaction. Also, as with any free-living diet
intervention study, the participants were not blinded and differences in
food choices between randomization groups other than those targeted
could have emerged. Analysis of other specific dietary changes that were
potentially beneficial related to CHD risk (e.g., substitution of unsatu-
rated fat for saturated or trans-fat, or the impact of dietary cholesterol
and egg intake), or corroboration of PREDIMED’s report (21) were not
possible. DMT intervention sessions presented strategies to reduce in-
take of foods like eggs that are often accompanied by bacon or sausage,
and nuts, to help reduce total fat intake. The potential influence of such
changes on CVD risk factors, as opposed to the primary aim of reduc-
ing risk of breast and colorectal cancers, was not part of the study de-
sign. Sacks and colleagues (22) demonstrated that a low-fat diet rich in
fruits and vegetables (DASH-diet compared with control), even inde-
pendent of sodium intake, reduced risk of hypertension. Multiple test-
ing is also an important consideration here, because CHD was a sec-
ondary trial outcome, and because these analyses focused on the subset
of trial participants who were normotensive and without CVD at base-
line, and whose baseline FFQ percentage of energy from fat was above
the median. However, these subset restrictions were imposed to avoid
biases due to postrandomization by statin use and due to the use of the
FFQ, with its substantial random measurement error component, for
eligibility screening, rather than being imposed on the basis of subset
data analytic results.
Data from randomized clinical trials of dietary pattern changes are
limited, and large long-term trials with clinical outcomes are even rarer.
PREDIMED (21) results increased interest in the Mediterranean-style
eating pattern as included within the systematic review of evidence un-
derlying the recommended 2015–2020 US Dietary Guidelines (37, 38).
Although PREDIMED involved a relatively high total fat intake (38%
of total calories) these WHI DMT data (1, 25, 36) reinforce findings
showing that reduced total fat intake, similar to a DASH-like pattern,
among US women with relatively high baseline fat intake, is a practi-
cal and effective alternative to the Mediterranean dietary pattern. This
approach is further consistent with reported cancer-related and dia-
betes prevention benefits (3, 36, 39). In addition, replacement of di-
etary fat with total carbohydrate did not increase all-cause mortality
(1), as was previously suggested by international study data (40), at
least not among healthy postmenopausal women in the United States.
It is also possible that compliant participants, who had frequent con-
tact with staff and other participants, could have adopted other ben-
eficial lifestyle changes beyond diet such as increased physical activ-
ity or stopping smoking, but the dietary changes reported here of-
fer novel insights beyond those available through purely observational
studies.
In conclusion, these WHI results demonstrate that a behaviorally
focused dietary intervention advocating reduction of total fat intake
through replacement with plant-based carbohydrate and protein foods
favorably reduced risk of CHD with no clear stroke impact. Dissemi-
nation of these approaches across a broader population seems plausible
but further exploration of specific foods, food groups, and eating pat-
terns best suited for personalized adaptation toward reducing risk for
all chronic diseases is highly warranted.
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